PALI

0.83999.24%
DA

Donald A. Williams

Independent Chairman of the Board

Mr. Donald A. Williams, also known as Don, BAcy, CPA. served as Director at Forte Biosciences, Inc. since June 2020 until September 17, 2024. He serves as the Chairman and President of the San Diego Venture Group. Mr. Williams is a veteran of the public accounting industry. He worked in Ernst & Young (E&Y) and was its Partner. He has a depth of experience includes a diverse set of growing domestic and international companies including venture financings, public equity offerings, public debt offerings, mergers and acquisitions and interaction with the US Securities and Exchange Commission and Public Company Accounting Oversight Board. He served as a Partner of Grant Thornton (GT). Previously, Mr. Williams served on the LBS Board since May 2019. Mr. Williams has also served as a member of the board of directors of Alphatic Spine, Inc. since 2015. His career focused on private and public companies in the technology and life sciences sectors. At Grant Thornton (from 2007 to 2014), he served as the National Leader of Grant Thornton’s Life Sciences Practice and the Managing Partner of its San Diego Office. He served as the Lead Partner for both E&Y and GT on multiple initial public offerings, secondary offerings, private and public debt financings, as well as numerous mergers and acquisitions. He served as Leader of the Pacific Southwest Strategic Growth Markets and the Venture Capital Advisory Group. He had been an Independent Director of Alphatec Holdings, Inc. since April 2015 until August 11, 2021. He served as an Independent Director at Alphatec Spine, Inc. since May 2015 until August 2021. He had been an Independent Director of Akari Therapeutics, Plc since June 29, 2016. He served as an Independent Director at Adhera Therapeutics, Inc. since November 2014 until December 20, 2019. He had been Independent Non-Executive Director at ImpediMed Limited since March 20, 2017 and served as its Independent Non-Executive Chairman since November 10, 2021 until September 28, 2023. From 2001 to 2014, he served as a Director of San Diego Venture Group and served on the Board of Directors of various charitable organizations in the communities. He serves as Independent Director of Palisade Bio, Inc. (Alternate name: Leading BioSciences, Inc) since April 27, 2021 and serves as its Independent Chairman of the Board since February 2024. He had been a Director of Proove Biosciences, Inc. since 2015. He received a B.A. in accountancy from Southern Illinois University and completed the Director education and certification program at the University of California, Los Angeles (UCLA) Anderson School of Business.

Positions